Strata Critical Medical, Inc. (SRTA) stock
SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3037% below fair value
$5.51−0.26 (-4.51%)
Close on Nov 13, 2026Market cap $487.45MP/E 10.8Yield –
Strata Critical Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Strata Critical Medical's profit margin for the twelve months ending Jun 30, 2026 was 15.7%. For fiscal 2025 it was 21.0%, against -18.6% the year before. The highest annual figure on record is 21.0% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21.0% | +39.6 |
| FY2024 | Dec 31, 2024 | -18.6% | +6.3 |
| FY2023 | Dec 31, 2023 | -24.9% | +54.4 |
| FY2021 | Sep 30, 2021 | -79.3% | −35.9 |
| FY2020 | Sep 30, 2020 | -43.4% | −8.6 |
| FY2019 | Sep 30, 2019 | -34.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -14.5% | −6.2 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 3.2% | +12.9 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -13.2% | +13.7 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 116.5% | +121.9 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -8.3% | +8.4 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -9.7% | −1.5 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -26.9% | +44.6 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -5.4% | −5.8 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -16.7% | +3.4 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -8.2% | +14.3 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -71.5% | −26.3 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | 0.4% | +38.9 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -20.1% | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -22.5% | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -45.2% | – |
| Q2 FY2020CQ1 2020 | Jun 30, 2020 | -38.5% | – |
See a number that looks wrong?